GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Fabp5 | decreases expression | EXP | | 6480464 | CTD | Dexamethasone results in decreased expression of FABP5 mRNA | PMID:35589016 | Fabp5 | multiple interactions | EXP | | 6480464 | CTD | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP5 mRNA | PMID:23428407 | Fabp5 | increases expression | ISO | FABP5 (Homo sapiens) | 6480464 | CTD | Dexamethasone results in increased expression of FABP5 mRNA | PMID:25047013 | Fabp5 | multiple interactions | ISO | FABP5 (Homo sapiens) | 6480464 | CTD | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of FABP5 mRNA | PMID:28628672 | |
Go Back to source page | Continue to Ontology report |